WEDINOS Philtre annual report 2022 to 2023
- Annual
This report shows benzodiazepines remain the most commonly identified group of psychoactive substances submitted, with a total of 18 identified.
WEDINOS analysis again highlights concerns of substance substitution within the UK drug market. Over the past year, Bromazolam was the most commonly identified benzodiazepine, and most often purchased with the belief that it was Diazepam. Because Bromazolam is more potent than Diazepam, this creates enhanced risk of harm and overdose as individual consumers are not aware of dose, time of onset of effects, duration of effects or contraindications with other substances.
Report downloads
WEDINOS Philtre annual report 2022 to 2023
PDF, 2MB
Download PDF - WEDINOS Philtre annual report 2022 to 2023 (2 MB)
Download PDFRelated reports
-
Harm reduction database Wales: Drug related mortality (Annual report 2025)
Executive summary Key findings and trends Take-home Naloxone (THN) – HRD Drug deaths in Wales – ONS Fatal / non-fatal drug poisoning reviews – HRD
Published on:
-
Data mining Wales: The annual profile for substance misuse 2024 to 2025
Executive summary Population level trends Children and young people (under 25 years) Adults aged 25-49 years Older adults, aged 50 years and above
Published on:
-
Needle and Syringe Programme Community Pharmacy – Understanding change in needle and syringe programme transactions within a community pharmacy setting
The investigation has found that the factors impacting on the number of transactions recorded on the Harm Reduction Database (HRD) are multifactorial and vary both within and across the health […]
Published on: 10th January 2024
-
Needle and Syringe Programme Activity in Wales Annual Report 2025 to 2026
This report for 2025-26 evidences the sustained and substantial reduction in the activity of people who use drugs (PWID) accessing needle and syringe programmes (NSP) across Wales since 2020. This […]
Published on: 27th July 2026
-
Specialist Needle and Syringe Programme – Understanding change in specialist needle and syringe programme
Needle and syringe programmes (NSP) provide comprehensive harm reduction interventions for the population of people who use drugs. NSP provision is a vital tool in minimising the transmission of blood-borne […]
Published on: 27th July 2026
-
Public Health Wales Research & Evaluation Highlights Report 2025 to 2026
Public Health Wales leads and supports research to improve health, reduce inequalities and strengthen public health services in Wales.
Published on:
Related data
-
Primary school children’s health and well-being dashboard data
Last reviewed: 18th June 2026
-
Secondary school children’s health and well-being dashboard data
Last reviewed: 27th November 2025